Table 2.
Mean ± Std. Deviation | t | |
---|---|---|
Age | ||
• Male | 49.48 ± 12.19 | -3.68** |
• Female | 58.34 ± 5.92 | |
PCR-T0 | ||
• Male = 28 | 890248.43 ± 1049454.60 | 2.22* |
• Female = 28 | 411320.44 ± 451668.92 | |
BMI-T0 | ||
• Male | 29.10 ± 3.86 | -2.83** |
• Female | 31.99 ± 4.15 | |
MBI-T1 | ||
• Male | 28.88 ± 3.83 | -2.74** |
• Female | 31.88 ± 4.71 | |
HRQoL-T0 | ||
• Male | 23.73 ± 15.89 | -3.43** |
• Female | 39.06 ± 19.66 | |
Symptom Severity-T0 | ||
• Male | 18.53 ± 10.30 | -3.12** |
• Female | 27.43 ± 12.28 | |
Symptom Hindrance-T0 | ||
• Male | 5.20 ± 6.66 | -3.27** |
• Female | 11.62 ± 8.57 | |
Depression-T0 | ||
• Male | 5.56 ± 5.88 | -3.52** |
• Female | 11.47 ± 7.19 | |
Depression-T1 | ||
• Male | 7.20 ± 6.46 | -2.32* |
• Female | 11.28 ± 7.69 |
Note: only significant results are presented, sample of male = 30 & female = 32
PCR-T0 Polymerase Chain Reaction time0, BMI-T0 body mass index time 0, BMI-T1 body mass index time 1, HRQoL-T0 health-related quality of life time 0
*P value: * ≤ .05, ** ≤ .001, *** ≤ .0001 at two tailed